Literature DB >> 2948387

Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.

C Jung-Hoffmann, H Kuhl.   

Abstract

The effect of a triphasic combination of ethinyl estradiol and levonorgestrel on the serum concentrations of total testosterone, free testosterone, and sex hormone-binding globulin as measured directly by radioimmunoassay and on the binding capacity of sex hormone-binding globulin was compared with that of a preparation containing ethinyl estradiol and desogestrel. Blood samples were taken on days 6, 11, 21, and 28 of a control cycle, the third cycle of treatment with either ethinyl estradiol-levonorgestrel or ethinyl estradiol-desogestrel (11 volunteers each), the third cycle of a 3-month washout period, and the third treatment cycle after crossover change of the preparations. There was a significant reduction in total testosterone by 16% during treatment with both preparations. Ethinyl estradiol-desogestrel increased the concentration (+175%) and binding capacity (+330%) of sex hormone-binding globulin to a much greater extent than with ethinyl estradiol-levonorgestrel (+92% and +160%). Contrary to this, a significant suppression of non-protein-bound testosterone by 35% was found during treatment with both oral contraceptives. The results demonstrate that an excessive elevation of the levels of sex hormone-binding globulin above the normal range does not cause a corresponding suppression of free testosterone. It is assumed that the decrease in the apparent binding affinity of high sex hormone-binding globulin concentrations to testosterone may be due to protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2948387     DOI: 10.1016/0002-9378(87)90238-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Defects of steroidogenesis.

Authors:  A Biason-Lauber; M Boscaro; F Mantero; G Balercia
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

2.  Oral contraceptives and sexuality in university women.

Authors:  N L McCoy; J R Matyas
Journal:  Arch Sex Behav       Date:  1996-02

3.  Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial.

Authors:  Kathryn E Ackerman; Vibha Singhal; Meghan Slattery; Kamryn T Eddy; Mary L Bouxsein; Hang Lee; Anne Klibanski; Madhusmita Misra
Journal:  J Bone Miner Res       Date:  2019-11-07       Impact factor: 6.741

Review 4.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 5.  Comparative pharmacology of newer progestogens.

Authors:  H Kuhl
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

6.  The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive.

Authors:  G V Upton; A Corbin
Journal:  Yale J Biol Med       Date:  1989 Sep-Oct

Review 7.  How Does Contraceptive Use Affect Women's Sexuality? A Novel Look at Sexual Acceptability.

Authors:  Salvatore Caruso; Gaia Palermo; Giuseppe Caruso; Agnese Maria Chiara Rapisarda
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

Review 8.  Facial Emotion Recognition and Emotional Memory From the Ovarian-Hormone Perspective: A Systematic Review.

Authors:  Dali Gamsakhurdashvili; Martin I Antov; Ursula Stockhorst
Journal:  Front Psychol       Date:  2021-05-20

Review 9.  The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.

Authors:  Y Zimmerman; M J C Eijkemans; H J T Coelingh Bennink; M A Blankenstein; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

10.  50 years of hormonal contraception-time to find out, what it does to our brain.

Authors:  Belinda A Pletzer; Hubert H Kerschbaum
Journal:  Front Neurosci       Date:  2014-08-21       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.